IFNA17 and Insulin resistance: When the butyrate produced by the GM decreases, the intestinal mucosa is damaged, permeability increases or immunity is imbalanced, immune cells infiltrate, and pro-inflammatory cytokines (INF-a, IL-6) increase, activating the inflammatory signaling pathway and leading to insulin resistance and GDM [60–63].